Congressional investigators are not waiting for November. They are already working.
In 2026, attorneys at Holland and Knight described what is happening inside the halls of the U.S. Congress: staffers are drafting investigative frameworks, cultivating external sources, and sending document preservation notices to healthcare companies. All of this - before a single vote has been cast in the 2026 midterm elections.
This is not a speculative risk. It is a present one. Healthcare has become the dominant domestic policy battleground of the decade, and the next congressional majority - whoever holds it - has already mapped the terrain. The organizations that treat oversight as a post-election problem are already behind.
This piece breaks down what investigators are targeting, why the scrutiny is bipartisan, what the Break Up Big Medicine Act means for vertically integrated health companies, and what specific steps healthcare leaders can take right now to assess their exposure.
